| Issue |
Med Sci (Paris)
Volume 41, Number 8-9, Août-Septembre 2025
|
|
|---|---|---|
| Page(s) | 683 - 689 | |
| Section | Repères | |
| DOI | https://doi.org/10.1051/medsci/2025108 | |
| Published online | 08 September 2025 | |
Le préservatif féminin
État des lieux, aspects pratiques et analyse des freins à son usage
The internal condom: overview, practical aspects and analysis of the barriers to its use
1
Service de Gynécologie-Obstétrique, Hôpital Pitié-Salpêtrière, DMU ORIGYNE Femmes-Mères-Enfants, APHP, Paris, France
2
Sorbonne Université, Faculté de Santé, Paris, France
a
This email address is being protected from spambots. You need JavaScript enabled to view it.
b
This email address is being protected from spambots. You need JavaScript enabled to view it.
c
This email address is being protected from spambots. You need JavaScript enabled to view it.
Résumé
Le préservatif interne (souvent appelé préservatif féminin), utilisable par les hommes et les femmes, est un dispositif médical à usage unique qui peut être mis en place plusieurs heures avant un rapport sexuel dans un objectif de prévention des infections sexuellement transmissibles (IST) et de contraception. Dans cet article, nous présentons un état des lieux de son usage ainsi qu’une synthèse des aspects techniques et législatifs. Nous verrons que ce type de préservatif présente une efficacité contraceptive quasi-similaire à son homologue masculin et une meilleure protection vis-à-vis des IST, mais qu’il reste très peu utilisé dans la population générale. Les freins potentiels à son usage seront aussi analysés et discutés.
Abstract
The internal condom (commonly referred to as the female condom), which can be used by both men and women, is a single-use medical device that can be inserted several hours before sexual intercourse for the prevention of sexually transmitted infections (STIs) and for contraception. This review presents an overview of its use, and a summary of the technical and regulatory aspects. We will see that this device is almost as effective as its external counterpart and offers better protection against STIs, but that it remains very underused in the general population. The potential barriers to its use will also be analyzed and discussed.
© 2025 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
